BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7383133)

  • 1. Dexamethasone in nonsuppressible Cushing's disease.
    Wortsman J; Blank JH
    N Engl J Med; 1980 Aug; 303(6):340. PubMed ID: 7383133
    [No Abstract]   [Full Text] [Related]  

  • 2. Dexamethasone in nonsuppressible Cushing's disease.
    Meikle AW; West CD; Tyler FH
    N Engl J Med; 1980 Aug; 303(6):340. PubMed ID: 6247657
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of ACTH by cortisol in dexamethasone-nonsuppressible Cushing's disease.
    Carey RM
    N Engl J Med; 1980 Jan; 302(5):275-9. PubMed ID: 6243171
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of 6-dehydro-16-methylene-hydrocortisone and dexamethasone on hypothalamo-hypophyseal-adrenal cortex-system].
    Berthold K
    Arzneimittelforschung; 1971 Oct; 21(10):1510-2. PubMed ID: 4333356
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of effects of 6-dehydro-16-methylene-hydrocortisone (STC 407) and dexamethasone on the suppression of the hypothalamo-pituitary-adrenal system.
    Berthold K; Arimura A; Schally AV
    Acta Endocrinol (Copenh); 1970 Mar; 63(3):423-30. PubMed ID: 4317301
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioimmunoassayable ACTH in dexamethasone nonsuppressible Cushing's syndrome.
    Rayyis SS; Bethune JE
    J Clin Endocrinol Metab; 1969 Sep; 29(9):1231-7. PubMed ID: 4309156
    [No Abstract]   [Full Text] [Related]  

  • 7. Alcohol-induced pseudo-Cushing's syndrome.
    Jeffcoate W
    Lancet; 1993 Mar; 341(8846):676-7. PubMed ID: 8095582
    [No Abstract]   [Full Text] [Related]  

  • 8. Paradoxical response to dexamethasone-suppression in Cushing's disease with adrenal hyperplasia.
    Winkler G; Huhnstock K; Graef V
    Rass Neurol Veg; 1969; 23(5):187-93. PubMed ID: 4328312
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of dexamethasone in the treatment of hypothalamo-pituitary syndrome, simulating early stages of Cushing's syndrome].
    Liashko KIa; Platovskaia LA; Oganesova VT; Bass ZhZh; Shekhter IM
    Sov Med; 1969 Aug; 32(8):41-6. PubMed ID: 5381923
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypothalamo-pituitary-adrenal axis in iatrogenic Cushing's syndrome.
    Tsan KW; Kuo CY
    Taiwan Yi Xue Hui Za Zhi; 1985 Aug; 84(8):936-43. PubMed ID: 3001216
    [No Abstract]   [Full Text] [Related]  

  • 11. Cushing's Syndrome in a 6-month-old Boy: A Rare Side-effect due to Inadequate use of Topical Corticosteroids.
    Ciccone S; Marini R; Bizzarri C; El Hachem M; Cappa M
    Acta Derm Venereol; 2016 Jan; 96(1):138-9. PubMed ID: 26038976
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypothalamo-pituitary-adrenal cortex system and the glucocorticoid kinetics in Cushing's syndrome treated with chlodithane and large doses of reserpine].
    Slavnov VN; Luchitskiĭ EV; Komissarenko IV; Markov VV; Cheban AK
    Ter Arkh; 1980; 52(7):124-8. PubMed ID: 6105729
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of large doses of reserpine on the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing's disease].
    Marova EI; Butrova SA; Kolesnikova GS
    Probl Endokrinol (Mosk); 1978; 24(2):17-21. PubMed ID: 205862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotransmitter studies of neuroendocrine pathology in depression.
    Carroll BJ; Greden JF; Haskett R; Feinberg M; Albala AA; Martin FI; Rubin RT; Heath B; Sharp PT; McLeod WL; McLeod MF
    Acta Psychiatr Scand Suppl; 1980; 280():183-99. PubMed ID: 6157302
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of various neurotropic drugs (L-dopa and alphamethyl-dopa) in Cushing's disease].
    González-Bárcena D; Siller-Rodríguez J; Guzmán-Rangel Y; López-Luna M
    Arch Invest Med (Mex); 1974; 5(2):99-104. PubMed ID: 4547950
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dopaminergic regulation of the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing disease].
    Sysoeva II; Dedov II
    Probl Endokrinol (Mosk); 1994; 40(1):22-6. PubMed ID: 7909372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cushing's disease: clinical manifestations and diagnostic evaluation.
    Kirk LF; Hash RB; Katner HP; Jones T
    Am Fam Physician; 2000 Sep; 62(5):1119-27, 1133-4. PubMed ID: 10997535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-night salivary cortisol measurement in the diagnosis of Cushing's syndrome.
    Carroll T; Raff H; Findling JW
    Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):344-50. PubMed ID: 18446140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of ethymisole on the hypothalamic-hypophyseal-adrenal system of rats in dexamethasone inhibition].
    Sapronov NS
    Biull Eksp Biol Med; 1971 Jun; 71(6):58-61. PubMed ID: 5097383
    [No Abstract]   [Full Text] [Related]  

  • 20. Subclinical Cushing's syndrome is a potential cause of metabolic dementia and rapidly progressive Alzheimer-type dementia.
    Guldiken S; Guldiken B
    Med Hypotheses; 2008 Nov; 71(5):703-5. PubMed ID: 18801622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.